Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/19/2002 | EP1214417A2 Nucleic acids and proteins from group b streptococcus |
06/19/2002 | EP1214413A1 Human paralogue of a head trauma induced cytoplasmatic calcium binding protein |
06/19/2002 | EP1214412A1 Rgs10b, a g-protein regulator expressed in osteoclasts |
06/19/2002 | EP1214409A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
06/19/2002 | EP1214404A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
06/19/2002 | EP1214403A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
06/19/2002 | EP1214401A2 Dna encoding the human serine protease c-e |
06/19/2002 | EP1214400A2 Zymogen activation system |
06/19/2002 | EP1214397A2 Method for the selective protection of proliferating normal cells and the selective eradication of tumor cells having an inactive p53 pathway |
06/19/2002 | EP1214349A2 Secreted soluble alpha2delta-2, alpha2delta-3 or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
06/19/2002 | EP1214344A1 Dipeptidyl peptidases |
06/19/2002 | EP1214343A2 T2r taste receptor family |
06/19/2002 | EP1214342A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
06/19/2002 | EP1214341A1 Dendritic cell membrane protein fire |
06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
06/19/2002 | EP1214334A1 Mutant fatty acid desaturase and methods for directed mutagenesis |
06/19/2002 | EP1214088A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
06/19/2002 | EP0900275B1 Methods and reagents for modulating apoptosis |
06/19/2002 | EP0879062B1 Nucleic acid delivery vehicle |
06/19/2002 | EP0870050B1 Toxic-protein expressing viruses and producer cell lines |
06/19/2002 | EP0859841B1 Protein/(poly)peptide libraries |
06/19/2002 | EP0826034A4 Generation of large genomic dna deletions |
06/19/2002 | EP0714510B1 Natural killer cell-specific antigen and antibodies that identify the same |
06/19/2002 | CN1354800A Recombinant newcastle disease virus RNA expression systems and vaccines |
06/19/2002 | CN1354797A DNA encoding plant lipase, transgenic plants and method for controlling senescence in plants |
06/19/2002 | CN1354795A Polypeptides having lactonohydrolase activity and nucleic acids encoding same |
06/19/2002 | CN1354791A Compositions for treatment and diagnosis of breast cancer and methods for their use |
06/19/2002 | CN1354790A Transformant for screening of inhibitors for human immunodeficiency virus |
06/19/2002 | CN1354789A Polypeptides having choline oxidase activity and nucleic acid encoding same |
06/19/2002 | CN1354788A Cyclic peptides |
06/19/2002 | CN1354755A Nucleotide and protein sequence of Nogo genes and methods based thereon |
06/19/2002 | CN1354668A Isolated peptides which bind to HLA-B35 molecules |
06/19/2002 | CN1354657A EGF-R antagonists for treating hypersecretion of mucus in lungs |
06/19/2002 | CN1353994A Method for creating human/goat hemopoietic stem cell heteroplastic transplantation model |
06/19/2002 | CN1086420C Method for cultivating sweet green pepper preventing cucumber mosaic virus |
06/18/2002 | US6407310 Method for preparing entomopathogenic nematodes for storage by mixing with non-fibrous cellulose particles of less than 300 μM |
06/18/2002 | US6407216 Vertebrate smoothened antibodies |
06/18/2002 | US6407063 Tumor antigens and CTL clones isolated by a novel procedure |
06/18/2002 | US6407046 Mutant EGIII cellulase, DNA encoding such EGIII compositions and methods for obtaining same |
06/18/2002 | US6406911 Recombitant cells with reporter sequence for reporter gene and heterologous sequence which codes cd4 or other cell surface receptors regulated by a protein specific to hiv |
06/18/2002 | US6406909 Soybean protein hydrolysate, yeast extract and wheat protein hydrolysate |
06/18/2002 | US6406908 Vanilloid receptor |
06/18/2002 | US6406899 Highly active alkaline phosphatase |
06/18/2002 | US6406885 Plant cell transformation vectors and dna code intimin |
06/18/2002 | US6406870 Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes |
06/18/2002 | US6406865 Method of inhibiting interaction of cells bearing CCR2 by Anti-CCR2 amino-terminal domain antibodies |
06/18/2002 | US6406842 Providing a sample suspected of containing enterovirus and a mixed cell culture comprising rhabdomyosarcoma cells and human mucoepidermoid cells, inoculating mixed cell culture with sample, observing inoculated culture for enterovirus |
06/18/2002 | US6406841 Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides |
06/18/2002 | US6406840 Tube segments and arrays and frozen cells |
06/18/2002 | US6406701 Reducing the susceptibility of t lymphocytes to hiv infection |
06/18/2002 | US6406700 Antigrowth agents for cancer, heat shock proteins bonding to proteins, complexes |
06/18/2002 | US6406694 Anti-CCR2 antibodies |
06/18/2002 | CA2365152A1 Method for specifically detecting tumour cells and their precursors in uterine cervical smears by simultaneously measuring at least 2 different molecular markers |
06/18/2002 | CA2315249C Biological properties of du-145 supernatant |
06/18/2002 | CA2098819C Dna sequences derived from the genome of the papillomavirus hpv39, their application to in vitro diagnostic and to the production of immunogen compositions |
06/13/2002 | WO2002046749A2 Screening method for identifying compounds that selectively induce interferon alpha |
06/13/2002 | WO2002046475A2 Method of detecting and treating tuberous sclerosis complex associated disorders |
06/13/2002 | WO2002046458A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
06/13/2002 | WO2002046430A2 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
06/13/2002 | WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
06/13/2002 | WO2002046418A2 Lipid-associated molecules |
06/13/2002 | WO2002046417A2 Adipocyte complement related protein zacrp3x2 |
06/13/2002 | WO2002046411A2 Intestinal proteins |
06/13/2002 | WO2002046409A2 Proteins and nucleic acids encoding same |
06/13/2002 | WO2002046407A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
06/13/2002 | WO2002046406A2 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof |
06/13/2002 | WO2002046404A2 Schizophrenia-related voltage-gated ion channel gene and protein |
06/13/2002 | WO2002046401A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue |
06/13/2002 | WO2002046387A2 Plant derived hydroxy phenyl pyruvate dioxygenases (hppd) resistant against triketone herbicides and transgenic plants containing these dioxygenases |
06/13/2002 | WO2002046386A2 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
06/13/2002 | WO2002046385A2 Enzymes |
06/13/2002 | WO2002046384A2 Kinases and phosphatases sequences, and use thereof |
06/13/2002 | WO2002046383A2 Protein modification and maintenance molecules |
06/13/2002 | WO2002046382A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
06/13/2002 | WO2002046381A2 Method for the prevention or reduction of haze in beverages |
06/13/2002 | WO2002046379A2 Glucuronyl c5-epimerase, dna encoding the same and uses thereof |
06/13/2002 | WO2002046376A1 Dehydrated antigen presenting cells usable for vaccination |
06/13/2002 | WO2002046375A1 In vitro synthesis of a layered cell sorted tissue |
06/13/2002 | WO2002046374A1 Preparation of spheroids |
06/13/2002 | WO2002046373A1 Method of collecting placental stem cells |
06/13/2002 | WO2002046372A1 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
06/13/2002 | WO2002046365A2 Method and apparatus to grow and mechanically condition cell cultures |
06/13/2002 | WO2002046359A2 Inducible highly productive raav packaging cell-lines |
06/13/2002 | WO2002046237A2 Humanized antibodies that recognize beta amyloid peptide |
06/13/2002 | WO2002046230A2 G-protein coupled receptors |
06/13/2002 | WO2002046227A2 Glp-1 fusion proteins |
06/13/2002 | WO2002046224A2 Compositions and methods relating to lung specific genes and proteins |
06/13/2002 | WO2002046220A2 Sequences upstream of the carp gene, vectors containing them and uses thereof |
06/13/2002 | WO2002046216A2 Human sprouty-4 polypeptide |
06/13/2002 | WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
06/13/2002 | WO2002046212A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
06/13/2002 | WO2002046208A2 Method of producing biospecific molecules by protein trans-splicing |
06/13/2002 | WO2002045766A1 Tissue equivalant for transplantation and process for producing the same |
06/13/2002 | WO2002045659A2 Novel therapeutics for heart failure and aging |
06/13/2002 | WO2002045524A2 Prolyl endoprotease from aspergillus niger |
06/13/2002 | WO2002045523A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
06/13/2002 | WO2002045506A1 Drug screening system |
06/13/2002 | WO2002029010A3 Method for obtaining in vitro mammal islet cells and uses thereof |
06/13/2002 | WO2002028419A3 Chemokine mutants in the treatment of multiple sclerosis |
06/13/2002 | WO2002026929A3 Kini-3 motor protein and methods for its use |